Honey as Adjuvant Leg ulcer Therapy: A randomised controlled trial of a honey-impregnated dressing for venous leg ulcers

ISRCTN ISRCTN06161544
DOI https://doi.org/10.1186/ISRCTN06161544
Secondary identifying numbers N/A
Submission date
08/02/2004
Registration date
22/03/2004
Last edited
13/02/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Mr Andrew Jull
Scientific

Clinical Trials Research Unit
University of Auckland
Private Bag 92019
Auckland
1003
New Zealand

Phone +64 9 373-7599 extn 84744
Email a.jull@ctru.auckland.ac.nz

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designMulti-centre
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study acronymHALT
Study objectivesThe HALT trial is an open-label, multi-centre, randomised,
controlled clinical trial assessing the effect of manuka honey on ulcer
healing, in patients with venous ulcers. Patients will be randomised to receive either manuka honey dressings or usual care (dressing of clinician's choice) for 12 weeks or until the ulcer has healed, whichever is sooner.
This intervention will be against a background of standard compression
therapy. Allocation is by central telephone randomisation. The sample is
stratified by ulcer size, ulceration duration and study centre. The objective of the study is to determine the effectiveness of manuka honey as an adjuvant to compression therapy in community-based patients with venous leg ulcers. Where the participant has more than one leg ulcer, the largest ulcer is selected as the reference ulcer.
Ethics approval(s)The Auckland Ethics Committee (Committee X). Date of approval: 09/12/2003 (ref: AKX/03/09/232)
Health condition(s) or problem(s) studiedVenous or mixed venous/arterial leg ulcers
InterventionHoney-impregnated calcium alginate dressing as an adjuvant to compression bandaging versus usual care (compression bandaging plus dressing of clinician's choice).
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Manuka honey
Primary outcome measureNumber of participants with completely healed reference ulcers at 12 weeks
Secondary outcome measuresTime to healing, percentage change in ulcer size, recurrence at six months, health related quality of life, number of dressing changes, costs, and adverse events.
Overall study start date01/05/2004
Completion date31/08/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants400
Key inclusion criteria400 community-based participants treated by district nurses, each with venous leg ulcer (clinical history, ABI >0.8) or mixed venous/arterial ulcer (clinical history, ABI >0.7), and being treated with compression bandaging.
ABI = Ankle Brachial Index
Key exclusion criteria1. Unable to provide informed consent
2. Have pre-exisiting diagnosis of diabetes
3. Have pre-existing diagnosis of rheumatoid arthritis
4. Have allergy to honey
Date of first enrolment01/05/2004
Date of final enrolment31/08/2005

Locations

Countries of recruitment

  • New Zealand

Study participating centre

Clinical Trials Research Unit
Auckland
1003
New Zealand

Sponsor information

Health Research Council of New Zealand
Research council

PO Box 5541
Wellesley St
Auckland
1001
New Zealand

Phone +64 9 379 8227
Email bscoggins@hrc.govt.nz
ROR logo "ROR" https://ror.org/00zbf3d93

Funders

Funder type

Research council

Primary funder: Health Research Council of New Zealand, grant No: 03/087.

No information available

Additional support: ApiMed Medical Honey Ltd and USL Medical Ltd

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/02/2008 Yes No